Correction to “Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)” [The Lancet Regional Health – Europe 41 (2024) 100915]

• Pascal Demoly,
• Mathieu Molimard,
• Jean-François Bergmann,
• Bertrand Delaisi,
• Amandine Gouverneur,
• Jade Vadel,
• Cédric Collin,
• Laurence Girard,
• Silvia Scurati,
• Philippe Devillier

Affiliations

Pascal Demoly

University Hospital of Montpellier and IDESP, University of Montpellier – INSERM – INRIA PreMediCal, Montpellier, France; Corresponding author.

Mathieu Molimard

Department of Medical Pharmacology, Bordeaux University, Bordeaux, France

Jean-François Bergmann

Department of Internal Medicine, Lariboisière Hospital, AP-HP, Université Paris-Cité, Paris, France

Bertrand Delaisi

Institut de l’Enfant, Clinique Marcel Sembat, Boulogne Billancourt, France

Amandine Gouverneur

IQVIA, RWS, France

Jade Vadel

IQVIA, RWS, France

Cédric Collin

IQVIA, RWS, France

Laurence Girard

Stallergenes Greer, France

Silvia Scurati

Stallergenes Greer, France

Philippe Devillier

VIM Suresnes – UMR_0892 & Clinical Research Unit, Airway Diseases Department, Foch Hospital, University Versailles Saint-Quentin, Suresnes, France